2019
DOI: 10.1038/s41467-019-13208-z
|View full text |Cite
|
Sign up to set email alerts
|

A network-based approach to identify deregulated pathways and drug effects in metabolic syndrome

Abstract: Metabolic syndrome is a pathological condition characterized by obesity, hyperglycemia, hypertension, elevated levels of triglycerides and low levels of high-density lipoprotein cholesterol that increase cardiovascular disease risk and type 2 diabetes. Although numerous predisposing genetic risk factors have been identified, the biological mechanisms underlying this complex phenotype are not fully elucidated. Here we introduce a systems biology approach based on network analysis to investigate deregulated biol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
59
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 60 publications
(62 citation statements)
references
References 71 publications
3
59
0
Order By: Relevance
“…Nordihydroguaiaretic acid and phloretin have been confirmed to prevent high-fat-diet-induced metabolic dysfunction in mice. The efficacy of ibrutinib in lowering adipose inflammatory responses was shown in zebrafish studies [ 81 ]. Quercetin shows its anti-inflammatory, anti-obesity, and anti-diabetic effects in human and animal studies [ 82 ].…”
Section: Discussionmentioning
confidence: 99%
“…Nordihydroguaiaretic acid and phloretin have been confirmed to prevent high-fat-diet-induced metabolic dysfunction in mice. The efficacy of ibrutinib in lowering adipose inflammatory responses was shown in zebrafish studies [ 81 ]. Quercetin shows its anti-inflammatory, anti-obesity, and anti-diabetic effects in human and animal studies [ 82 ].…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, it could be a powerful instrument to link pharmacological and disease data, thereby providing a tool to evaluate the pleiotropic effect of large compound libraries and existing drugs 6 . There are many examples of the successful identification of novel therapeutic strategies based on systems biology [7][8][9][10] . In this study, bioactive compounds with known protein targets have been screened in silico using a systems biology-based approach 11 for their potential to target CLL microenvironment.…”
Section: Systems Biology Drug Screening Identifies Statins As Enhancementioning
confidence: 99%
“…hypertension, diabetes, etc), which also brings potentially adverse side effects, such as gastrointestinal problems, arrhythmias, weight gain, insomnia, dizziness, asthenia, etc. [ 15 , 16 ]. However, evidence suggests that an appropriate lifestyle can help manage and prevent MetS and its associated factors [ 17 ].…”
Section: Introductionmentioning
confidence: 99%